Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Carter Berezay who wrote (413)	2/2/1999 11:10:00 PM
From: Larry G.	Respond to of 792

I change my mind on the significance of this announcement. They state they plan to be in clinical trials by 1st quarter of 2000. They do not say that lightly. When you put everything together Eye Drug, Acne Drug, Catheter Drug, (They will eventually be in systemic infection where the big money is(30 billion target market)) you start to realize this company has a LOT of potential. The price may or may not move tomorrow but when the public understands this company the price should grow. They are still working on the joint venture agreement. This will help to.

To: Carter Berezay who wrote (413)	2/3/1999 12:17:00 AM
From: Larry G.	Read Replies (1) \| Respond to of 792

Hi Carter, One thing to are advantage with this announcement, everyone knows what a pimple is. People also know pimples are bad and people will pay money to get rid of them. Many people do not know what a catheter is. This probably will have a wider appeal than Phase 1 announcement.